-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Rigel Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2017 to Q1 2024.
- Rigel Pharmaceuticals Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$5.01M, a 23% decline year-over-year.
- Rigel Pharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$5.74M, a 92.2% increase from 2022.
- Rigel Pharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$73.8M, a 1355% decline from 2021.
- Rigel Pharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was $5.88M.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)